Wells Fargo & Company Blueprint Medicines Corp Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Wells Fargo & Company holds 66,657 shares of BPMC stock, worth $6.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

66,657

Previous 28,393 134.77%

Holding current value

$6.42 Million

Previous $3.06 Million 101.41%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$84.1 - $120.5 $3.22 Million - $4.61 Million	38,264 Added 134.77%	66,657 $6.16 Million
Q2 2024 Aug 13, 2024	BUY	$85.18 - $108.78 $207,924 - $265,531	2,441 Added 9.41%	28,393 $3.06 Million
Q1 2024 May 10, 2024	BUY	$73.17 - $99.79 $95,413 - $130,126	1,304 Added 5.29%	25,952 $2.46 Million
Q4 2023 Feb 09, 2024	SELL	$43.96 - $92.84 $1.24 Million - $2.62 Million	-28,270 Reduced 53.42%	24,648 $2.27 Million
Q3 2023 Nov 13, 2023	SELL	$46.9 - $66.0 $143,560 - $202,026	-3,061 Reduced 5.47%	52,918 $2.66 Million
Q2 2023 Aug 15, 2023	BUY	$42.2 - $66.37 $456,646 - $718,189	10,821 Added 23.96%	55,979 $3.54 Million
Q1 2023 May 12, 2023	BUY	$37.97 - $50.0 $1.37 Million - $1.8 Million	36,089 Added 397.94%	45,158 $2.03 Million
Q4 2022 Feb 13, 2023	SELL	$41.06 - $66.48 $19,667 - $31,843	-479 Reduced 5.02%	9,069 $397,000
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $28,460 - $44,289	-570 Reduced 5.63%	9,548 $629,000
Q2 2022 Aug 12, 2022	SELL	$45.23 - $70.15 $1.44 Million - $2.23 Million	-31,751 Reduced 75.83%	10,118 $511,000
Q1 2022 May 16, 2022	SELL	$54.1 - $110.08 $1.25 Million - $2.54 Million	-23,059 Reduced 35.51%	41,869 $2.68 Million
Q4 2021 Feb 14, 2022	SELL	$94.25 - $115.99 $1.72 Million - $2.12 Million	-18,248 Reduced 21.94%	64,928 $6.95 Million
Q3 2021 Nov 15, 2021	BUY	$80.98 - $109.47 $134,831 - $182,267	1,665 Added 2.04%	83,176 $8.55 Million
Q2 2021 Aug 16, 2021	SELL	$82.78 - $101.0 $914,222 - $1.12 Million	-11,044 Reduced 11.93%	81,511 $7.17 Million
Q1 2021 May 13, 2021	BUY	$90.71 - $108.28 $2.78 Million - $3.32 Million	30,684 Added 49.59%	92,555 $9 Million
Q4 2020 Feb 09, 2021	BUY	$92.08 - $124.48 $1.64 Million - $2.21 Million	17,769 Added 40.29%	61,871 $6.94 Million
Q3 2020 Nov 05, 2020	SELL	$66.45 - $92.7 $690,947 - $963,894	-10,398 Reduced 19.08%	44,102 $4.09 Million
Q2 2020 Aug 13, 2020	BUY	$57.09 - $79.27 $544,924 - $756,632	9,545 Added 21.23%	54,500 $4.25 Million
Q1 2020 May 14, 2020	BUY	$48.11 - $82.22 $2.16 Million - $3.7 Million	44,955 New	44,955 $2.63 Million

Others Institutions Holding BPMC

# of Institutions

352

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.76B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Blueprint Medicines Corp Transaction History